0001209191-23-043276.txt : 20230725
0001209191-23-043276.hdr.sgml : 20230725
20230725122837
ACCESSION NUMBER: 0001209191-23-043276
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230721
FILED AS OF DATE: 20230725
DATE AS OF CHANGE: 20230725
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PASSERI DANIEL R
CENTRAL INDEX KEY: 0001190121
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38327
FILM NUMBER: 231107619
MAIL ADDRESS:
STREET 1: 40 GUEST STREET
CITY: BOSTON
STATE: MA
ZIP: 02135
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cue Biopharma, Inc.
CENTRAL INDEX KEY: 0001645460
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473324577
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 40 GUEST STREET
CITY: BOSTON
STATE: MA
ZIP: 02135
BUSINESS PHONE: 617-949-2680
MAIL ADDRESS:
STREET 1: 40 GUEST STREET
CITY: BOSTON
STATE: MA
ZIP: 02135
FORMER COMPANY:
FORMER CONFORMED NAME: Imagen Biopharma, Inc.
DATE OF NAME CHANGE: 20150617
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-07-21
0
0001645460
Cue Biopharma, Inc.
CUE
0001190121
PASSERI DANIEL R
C/O CUE BIOPHARMA, INC.
40 GUEST STREET
BOSTON
MA
02135
1
1
0
0
CHIEF EXECUTIVE OFFICER
0
Stock Option (right to buy)
4.20
2023-07-21
4
A
0
450000
0.00
A
2033-07-20
Common Stock
450000
450000
D
This stock option grant becomes exercisable in twenty four equal monthly installments beginning on August 21, 2023.
/s/ Daniel Passeri by Colin Sandercock, attorney-in-fact
2023-07-25